S&P 500: 662.29 -0.6% NASDAQ 100: 593.72 -0.6% Dow Jones: 466.41 -0.2%

Andreas Halvorsen’s TMO Holdings & Trades

First Buy
Q2 2013
Duration Held
35 Quarters
Largest Add
Q2 2013
+8.69 M Shares
Current Position
793,187 Shares
$459.61 M Value

Andreas Halvorsen's TMO Position Overview

Andreas Halvorsen (via Viking Global Investors Lp) currently holds 793,187 shares of Thermo Fisher Scientific Inc. (TMO) worth $459.61 M, representing 1.22% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 35 quarters.

Based on 13F filings, Andreas Halvorsen has maintained a strategic position in TMO, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2013, adding 1.88 M shares. Largest reduction occurred in Q2 2015, reducing 3.32 M shares.

Analysis based on 13F filings available since 2013 Q2

Andreas Halvorsen's Thermo Fisher Scientific (TMO) Holding Value Over Time

Track share changes against reported price movement

Quarterly Thermo Fisher Scientific (TMO) Trades by Andreas Halvorsen

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2025 +793,187 New Buy 793,187 $579.45
Q2 2024 -128,489 Sold Out 0 $0.00
Q1 2024 -409,996 Reduce 76.14% 128,489 $581.21
Q4 2023 -361,230 Reduce 40.15% 538,485 $530.79
Q3 2023 +66,482 Add 7.98% 899,715 $506.17
Q2 2023 -23,603 Reduce 2.75% 833,233 $521.75
Q1 2023 +17,310 Add 2.06% 856,836 $576.37
Q4 2022 +245,989 Add 41.44% 839,526 $550.69
Q3 2022 -269,050 Reduce 31.19% 593,537 $507.19
Q2 2022 +377,891 Add 77.96% 862,587 $543.28
Q1 2022 +273,638 Add 129.65% 484,696 $590.65
Q4 2021 +28,821 Add 15.82% 211,058 $667.24
Q3 2021 -829,164 Reduce 81.98% 182,237 $571.33
Q2 2021 +149,514 Add 17.35% 1.01 M $504.47
Q1 2021 +784,070 Add 1007.58% 861,887 $456.38
Q4 2020 -1.3 M Reduce 94.35% 77,817 $465.79
Q3 2020 -356,921 Reduce 20.58% 1.38 M $441.52
Q2 2020 +1.73 M New Buy 1.73 M $362.34
Q2 2019 -1.15 M Sold Out 0 $0.00
Q1 2019 +598,131 Add 109.17% 1.15 M $273.72
Q4 2018 -1.33 M Reduce 70.82% 547,906 $223.79
Q3 2018 -602,542 Reduce 24.29% 1.88 M $244.08
Q2 2018 +1.62 M Add 186.85% 2.48 M $207.14
Q1 2018 +50,164 Add 6.16% 864,681 $206.46
Q4 2017 +814,517 New Buy 814,517 $189.88
Q3 2015 -207,527 Sold Out 0 $0.00
Q2 2015 -3.32 M Reduce 94.12% 207,527 $129.76
Q1 2015 -2.25 M Reduce 38.96% 3.53 M $134.34
Q4 2014 -2.19 M Reduce 27.46% 5.79 M $125.29
Q3 2014 -294,778 Reduce 3.56% 7.98 M $121.70
Q2 2014 -1.4 M Reduce 14.45% 8.27 M $118.00
Q1 2014 -707,017 Reduce 6.81% 9.67 M $120.24
Q4 2013 -195,114 Reduce 1.85% 10.38 M $111.35
Q3 2013 +1.88 M Add 21.65% 10.57 M $92.15
Q2 2013 +8.69 M Add 0.00% 8.69 M $84.63

Andreas Halvorsen's Thermo Fisher Scientific Investment FAQs

Andreas Halvorsen first purchased Thermo Fisher Scientific Inc. (TMO) in Q2 2013, acquiring 8,689,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Andreas Halvorsen has held Thermo Fisher Scientific Inc. (TMO) for 35 quarters since Q2 2013.

Andreas Halvorsen's largest addition to Thermo Fisher Scientific Inc. (TMO) was in Q2 2013, adding 8,689,600 shares worth $735.4 M.

According to the latest 13F filing for Q4 2025, Andreas Halvorsen's firm, Viking Global Investors Lp, owns 793,187 shares of Thermo Fisher Scientific Inc. (TMO), valued at approximately $459.61 M.

As of the Q4 2025 filing, Thermo Fisher Scientific Inc. (TMO) represents approximately 1.22% of Andreas Halvorsen's publicly disclosed stock portfolio, making it one of their key holdings.

Andreas Halvorsen's peak holding in Thermo Fisher Scientific Inc. (TMO) was 10,570,770 shares, as reported at the end of Q3 2013.